Clinical trials
Phase 3 Migraine Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
114 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 7 |
| 2006 | 10 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 1 |
| 2015 | 9 |
| 2016 | 12 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 9 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 89 |
| Recruiting | 10 |
| Terminated | 7 |
| Unknown status | 3 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 11 |
| Allergan | 9 |
| Pfizer | 9 |
| Eli Lilly and Company | 8 |
| AbbVie | 7 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 5 |
| Amgen | 4 |
| Axsome Therapeutics, Inc. | 4 |
| Abbott | 3 |
| Alder Biopharmaceuticals, Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Migraine Disorders | 114 |
| Headache | 24 |
| Hyperacusis | 5 |
| Migraine without Aura | 5 |
| Photophobia | 5 |
| Epilepsy | 4 |
| Migraine with Aura | 4 |
| Nausea | 4 |
| Foramen Ovale, Patent | 3 |
| Pain | 3 |
Trials
Showing 1 to 25 of 114. Each trial links to its page on Pharma Observatory.
14 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.